Please login to the form below

Not currently logged in
Email:
Password:

GSK's Ellen Strahlman joins med tech firm BD

Will serve as the US company's chief medical officer

BD Dr Ellen StrahlmanNew Jersey-based medical technology company BD (Becton, Dickinson and Company) has appointed Dr Ellen Strahlman to the newly created role of chief medical officer and senior VP, research and development.

Dr Strahlman joins the firm from GlaxoSmithKline (GSK), which she joined in 2008, serving first as chief medical officer, and then senior medical advisor in the office of the CEO and global head of neglected tropical diseases.

Prior to her time with GSK, Dr Strahlman held executive leadership roles at Merck & Co, Novartis, Pfizer and Bausch & Lomb.

In her new role at BD Dr Strahlman will oversee the company's medical affairs and research and development functions.

"I am very pleased that Dr Strahlman will be joining BD at a time when we are strategically focused on driving growth through innovation and customer focus," said BD's CEO Vincent Forlenza. "She brings extensive experience as a senior physician and leader in the pharmaceutical and medical device industries, and her patient-centric approach aligns with our focus on providing innovative solutions to address the healthcare needs of customers and patients."

Headquartered in Franklin Lakes, New Jersey, BD develops, manufactures and sells medical devices, instrument systems and reagents.

14th March 2013

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...

Infographics